Biomet CEO makes the case that Joint Replacements lower overall healthcare costs

JOINT-REPLACEMENT DEVICES A SOCIETAL BARGAIN (Orthopedics This Week) We read a lot about the costs of medical technology to patient care but a closer look reveals that medical technology prices in the United States have remained consistently low for 20 years. According to Jeffrey R. Binder, president and CEO of Biomet Inc. and a member of the board of directors at the Advanced Medical Technology Association, writing for the online publication Phily.com, medical technology prices have grown at about an average annual rate of 1%—half the rate of prices in the overall economy. Binder writes that ...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top